Two-Year Follow-Up study tests gut disease Drug's staying power
NCT ID NCT07222189
Summary
This study aims to learn about the long-term safety and effectiveness of an investigational drug called balinatunfib for adults with Crohn's disease or ulcerative colitis. It will follow about 325 people who have already completed a previous 1-year study with this medication. The main goal is to see how well people tolerate the drug and whether it continues to help control their inflammatory bowel disease over an additional 2 years of treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN'S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.